STERIS plc (STE)

Market Cap	20.80B -4.7%
Revenue (ttm)	5.94B +8.7%
Net Income	782.30M +27.3%
EPS	7.93 +27.8%
Shares Out	98.08M
PE Ratio	26.75
Forward PE	19.03
Dividend	$2.52 (1.19%)
Ex-Dividend Date	Jun 8, 2026

Volume	1,392,265
Open	215.41
Previous Close	215.98
Day's Range	211.33 - 216.65
52-Week Range	195.14 - 269.44
Beta	0.95
Analysts	Buy
Price Target	275.67 (+27.95%)
Earnings Date	May 11, 2026

About STE

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 1, 1992
• Employees: 17,787
• Stock Exchange: NYSE
• Ticker Symbol: STE
• Website: https://www.steris.com

Financial Performance

In fiscal year 2026, STERIS's revenue was $5.94 billion, an increase of 8.73% compared to the previous year's $5.46 billion. Earnings were $782.30 million, an increase of 27.28%.

Analyst Summary

According to 3 analysts, the average rating for STE stock is "Buy." The 12-month stock price target is $275.67, which is an increase of 27.95% from the latest price.

Price Target

$275.67

(27.95% upside)

Analyst Consensus: Buy